Markets have had an uncertain week, pulled in different directions by AI demand hopes and US government shutdown worries.

() -Johnson & Johnson is in discussions to buy Protagonist Therapeutics, a source familiar with the matter told . Shares of ...

U.S. President Donald Trump threatened to hike tariffs against China and cancel a planned meeting with President Xi Jinping, ...

Wall Street is looking to U. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after ...

OTTAWA (Reuters) -Reviving the proposed Keystone XL oil pipeline from Alberta to the U.S. could play a part in tightening U.S ...

A monthslong calm on Wall Street is shattering Friday, and U.S. stocks are falling after President Donald Trump threatened to ...

(Reuters) -Drugmaker Bristol Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital ...

Brazil's government on Friday announced a new real estate funding framework that loosens rules on the mandatory allocation of ...

The IRS finalized 2026 brackets and standard deductions—shifting thresholds upward under the One Big Beautiful Bill and ...

Waller, seen as top contender to succeed Chair Jerome Powell next year, told CNBC the interview was "all serious economics." ...

Warren Buffett is one of the best stock pickers of all time. He says that unless Americans want to spend hours researching ...

Securities and Exchange Commission (SEC) said Indian authorities have not yet acted on its requests to serve summons and ...